Oruka Therapeutics, Inc. (ORKA)

NGM – Real Time Price. Currency in USD

106.11

+1.43 (1.37%)

Market open: Aug 12, 2026, 2:22 PM EDT

103.00

-1.68 (-1.60%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-83K

-27K

-111K

-114K

Gross Profit

-83K

-27K

-111K

-114K

Operating expenses (excl. COGS)

-122M

-88M

-7M

-10M

Operating Income

-122M

-88M

-7M

-10M

Non-operating income, total

17M

-85K

Pretax income

-105M

-84M

-5M

-10M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-105M

-84M

-5M

-10M

Discontinued operations

Net income

-105M

-84M

-5M

-10M

Dilution adjustment

Preferred dividends

Oruka Therapeutics, Inc. (ORKA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Oruka Therapeutics, Inc. (ORKA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Oruka Therapeutics, Inc. (ORKA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Oruka Therapeutics, Inc. (ORKA)

Income Statement (Annual)

Income Statement (Annual)